High incidence of sotrovimab resistance and viral persistence after treatment of immunocompromised patients infected with the SARS-CoV-2 Omicron variant

Sammy Huygens(Ghent University Hospital), Bart Rijnders(Rega Institute for Medical Research), Marion Koopmans(National Institute for Public Health and the Environment), Arvind Gharbharan(Erasmus MC), Bas B. Oude Munnink(University of Amsterdam)
medRxiv
April 6, 2022
Cited by 11


Related Papers